CS Paper Radar

Agentic AI uncovers conserved cross-tissue protein co-abundance programs inaccessible to single-dataset analysis

Dehao Wu, Runyu Guan, Qiqi Xie, Yang Li, Haohan Wang

cs.AI q-bio.MN ·submitted 2026-08-29 01:55 UTC · v2
code/data

Abstract

Protein co-abundance clusters preserved across tissues can nominate shared disease mechanisms and therapeutic targets, particularly where proteins implicated in organ-confined diseases converge in other tissues. Yet cross-tissue proteomic studies have examined pre-selected tissue pairs, leaving most combinations, and non-obvious relationships among them, unexplored. Exhaustive comparison requires consistently assessing thousands of candidate clusters from hundreds of tissue-pair networks across heterogeneous evidence, a scale beyond manual curation. We present an LLM-agent framework for large-scale, evidence-grounded comparison of tissue-specific protein co-abundance networks. From sample-level proteomic data, it constructs tissue networks, derives conserved clusters for each tissue pair, integrates evidence from expression atlases, interaction and complex databases, pathways, disease associations and the literature, and proposes mechanistic hypotheses in which every conclusion cites its evidence. Applied to all 231 pairs among 22 human tissues and sample groups, it identified 1,825 conserved clusters in 216 tissue pairs. Co-abundance relationships were shared beyond chance in 76% of pairs, including unrelated organs, and shared clusters were only weakly associated with abundance similarity. Clusters were enriched 3.7- to 6.9-fold for known interactions and complex memberships, and 379 of 793 testable clusters replicated in independent CPTAC proteomes. Some clusters pointed to relationships absent from current databases: one shared by liver and bone marrow linked three genes causing inherited white matter disorders, suggesting a common mechanism via the integrated stress response. Conserved co-abundance clusters thus offer a hypothesis-generating resource for studying disease proteins beyond the affected organ. Code: https://github.com/jacob20030316-crypto/Protein_Co_Abundance_Agent

Comment
12 pages, 6 figures

Closest papers

Nearest neighbours by meaning across the whole index.

ReLaG: A Scalable Framework Generalizing Random Splits to Data with Latent Relations

cs.LG cs.AI ·2026-09-29 ·Anthony Lavertu, Jacob Cote, Sophie Gobeil, Jacques Corbeil, Isabeau Premont-Schwarz +1 more
code/data similarity 0.60
Abstract

Random splitting can yield non-independent train--test subsets when a dataset contains related samples, as is common in certain applications such as biochemical studies. This leads to overly optimistic generalization estimates. Here, we introduce ReLaG, a modality-agnostic framework that models sample relatedness through a hierarchical latent-variable process and infers groups of related samples using proximity graphs and community detection to produce independent train--test subsets. Across molecular and protein datasets, ReLaG matches existing relation-aware methods while scaling substantially better, enabling splits at previously impractical dataset sizes. We further introduce a label-free procedure that adapts the splitting resolution to production data, aligning evaluation with the intended deployment setting. ReLaG's inferred groups provide a cheap estimate of effective dataset size, enabling diversity-aware dataset scaling. ReLaG is open source and can be installed with pip install relag.

0.31

Bridging Graph and Pairwise Learning for Gene Regulatory Network Inference from scRNA-seq Data

cs.AI q-bio.GN ·2026-11-10 ·Hang Li, Jiaxin Qi, Yan Cui, Yuhua Zheng, Jianqiang Huang
publishedbenchmarkcode/data similarity 0.59
Abstract · Accepted to Bioinformatics

Motivation: Gene regulatory networks (GRNs) capture the underlying interactions through which transcription factors (TFs) regulate genes. Based on gene expression data, existing GRN inference approaches generally fall into two categories: graph-based methods, which model the GRN as a whole graph, and pairwise-based methods, which decompose the GRN into individual TF-target gene pairs for modeling. However, each approach exhibits limitations that are precisely the strengths of its counterpart. Graph-based methods tend to overfit due to their reliance on a single training graph, whereas pairwise-based methods benefit from abundant TF-target training pairs. In contrast, pairwise-based methods overlook the global topological structure, which is essential for comprehensively capturing regulatory mechanisms. Results: To address these limitations, we propose scGPL, an end-to-end unified framework that jointly models global regulatory topology and local interactions. scGPL extracts macro-level features from the global regulatory graph and introduces a dynamic, importance-guided subgraph sampling mechanism to capture fine-grained local dependencies. By fusing global representations with subgraph-enhanced local features, our framework bridges the gap between the two paradigms, incorporating essential whole-graph topological dependencies while retaining the data abundance advantage of pairwise methods. Extensive experiments on seven benchmark datasets demonstrate that scGPL consistently achieves state-of-the-art performance, with up to 13.7% improvement over the strongest baseline, validating the effectiveness of our integrative design. Availability and implementation: The source code is maintained on GitHub (https://github.com/talent-hang/scGPL), and the datasets and versioned releases are archived at https://doi.org/10.5281/zenodo.21608485 for reproducibility.

0.39

Conserved Immune Topology Improves Pathology Foundation Model Generalization for Cross-Cancer MSI-H Prediction

cs.CV ·2026-09-04 ·Dasari Naga Raju
published similarity 0.58
Abstract · Accepted at the ECCV 2026 Workshop on Medical Foundation Models and Benchmarks (MedFM-Bench). 15 pages, 2 figures

Pathology foundation models integrated with multiple instance learning achieve competitive accuracy within single-cancer cohorts, yet cross-cancer generalization remains unresolved due to organ-specific histological and architectural differences. In this paper, we propose Conserved Immune Topology (CIT), a lightweight spatial representation for cross-cancer MSI-H prediction that augments foundation-model embeddings with biologically motivated immune descriptors. CIT uses unsupervised clustering to identify immune-associated tiles, then encodes tertiary lymphoid structures, peritumoral immune reactions, multi-scale tumor-infiltrating lymphocyte density, and immune-tumor mixing from frozen foundation-model embeddings and tile coordinates without requiring annotations or target-domain data. The proposed method was evaluated under cross-site and cross-cancer settings using CPTAC-COAD and TCGA-STAD cohorts, which introduce scanner variability, distribution shifts, and organ-specific architectural variations. Zero-shot cross-cancer transfer with CIT increased TransMIL AUC from 0.6627 to 0.7161, an absolute gain of 0.0534 (p=0.003), with consistent improvements across all three MIL aggregators. These results suggest that spatial immune topology provides potentially an organ-invariant representation for MSI-H prediction, supporting cross-cancer generalization of pathology foundation models.

0.34

CellPlex: Benchmarking Single-Cell Spatial Proteomics Prediction from H&E

cs.CV ·2026-11-02 ·Zijun Gao, Yijiang Chen, Xiangde Luo, Pheng-Ann Heng
benchmark similarity 0.57
Abstract

Spatial proteomics measures tens of proteins in every cell of a tissue section, but its cost confines it to small research cohorts, whereas hematoxylin and eosin (H\&E) slides exist for nearly every patient. Inferring single-cell spatial proteomics from H\&E would bring its analyses to routine pathology, and a growing number of virtual staining models pursue this goal. Each is evaluated on its own cohort, panel and pixel-level metric, and released models transfer poorly to new cohorts, leaving open which approach to build on and which proteins H\&E can reveal. We introduce CellPlex, a benchmark that poses the task at the level of the cell: seven cohorts with same-section H\&E and multiplexed immunofluorescence, from colorectal and breast cancer to lymph-node metastases, bone marrow and glioma, with 717 samples, 44.8 million cells and 149 proteins, processed by one pipeline into per-cell targets. Pathology foundation models (PFMs) are adapted with one cell-level protocol, specialist models are fine-tuned under a matched budget, and all are scored on the same cells. Adapted PFMs are the most accurate models on every cohort, ahead of the specialists even after fine-tuning, but keep less than half of their accuracy on cohorts they were not trained on. Which proteins can be predicted depends on the tissue, not on how many cells were measured for them. By fixing the cells, targets and splits on which predictions are judged, CellPlex sets a common standard for inferring costly molecular measurements from routine H\&E and shows how far H\&E can stand in for spatial proteomics. We will release the data, splits, evaluation code and baselines as a testbed for developing and comparing future pathology foundation models and virtual staining methods.

0.21

spora: A Unified Multimodal Dataset and Platform for Spatial Proteomics

cs.CV cs.AI ·2026-10-15 ·Benedikt von Querfurth, Johann Wenckstern, Eeshaan Jain, Lukas Klein, Phil Cheng +7 more
top venuebenchmark similarity 0.57
Abstract · Accepted to NeurIPS 2026

Spatial proteomics (SP) captures the molecular composition and spatial organization of tissues at single-cell resolution, opening a direct view of the cellular ecosystems that drive disease. Protein panels, acquisition platforms, and tissue contexts differ from one cohort to the next, and a coherent picture of tissue biology can only emerge from models trained to bridge this heterogeneity. Foundation models offer the natural path forward, but their training depends on large, harmonized corpora that span platforms, panels, and cohorts. No public resource currently approaches that scale; available data sit in small, narrowly scoped releases with incompatible formats and conventions. We present $\texttt{spora}$, a large-scale multimodal SP dataset of 13,546 standardized multiplex images from 5,477 patients across 35 cohorts and five major SP technologies. Curated with biomedical experts, $\texttt{spora}$ provides model training-ready formats together with cell and tissue segmentations, structured clinical metadata, and, where available, paired H&E enabling the training of virtual staining models. It is complemented by $\texttt{spora [io]}$, a unified interface for tiling, sampling, and standardization across all cohorts and modalities, and $\texttt{spora [bench]}$, a benchmark suite spanning cell phenotyping, diagnostic and therapeutic prediction as well as virtual staining tasks across twelve cohorts that places current SP foundation models on common ground against task specific baselines.

0.52

CellChain: Benchmarking Cross-Scale Evidence Use for Perturbation Reasoning

cs.DB q-bio.GN ·2026-10-12 ·Xue Xia, Yue Wang, Shuizhou Chen, Lang Yu, Hao Wu +4 more
benchmark similarity 0.56
Abstract · 21 pages, 6 figures

Recent advances in foundation models and large-scale cellular perturbation datasets have driven growing interest in using LLMs to predict and reason about cellular responses. Biological reasoning in this setting involves relating molecular mechanisms, cellular responses, and functional outcomes across scales. Evaluating foundation models therefore requires assessing not only whether their predictions are correct, but also how those predictions depend on the biological evidence provided. We introduce CellChain, an experimentally grounded benchmark comprising 590 biological cases and 2,360 matched evidence-condition instances across gene-dependency prediction, cytokine-axis identification, and drug-sensitivity ranking. CellChain links perturbation experiments and external biological resources through a provenance-aware evidence graph spanning molecular, pathway, transcriptional, and phenotypic information. Task-specific conditions vary evidence coverage, composition, or assignment while preserving questions, candidate answers, reference targets, and scoring rules. Across 18 foundation models, the highest accuracies under prespecified target-evidence conditions are 57.5%, 75.5%, and 70.8%, respectively, and broader evidence coverage does not consistently improve accuracy. On the drug-sensitivity benchmark cohort, matched reference histories outperform swapped histories by an average of 13.0 percentage points in cluster-weighted accuracy. Decision-transition analysis separates corrections, newly introduced errors, and wrong-answer switches, revealing substantial answer changes hidden by small net accuracy differences. CellChain provides controlled comparisons for attributing changes in model predictions to prespecified expansions of biological context, including changes in evidence coverage, composition, and biological assignment.

0.19

OmicSync: Reliability-Aware Spatial Multi-Omics Clustering with Evidence-Constrained LLM Reasoning

cs.CV ·2026-08-24 ·Rabeya Tus Sadia, Qiang Ye, Qiang Cheng
similarity 0.56
Abstract

Spatial multi-omics technologies jointly profile gene expression, surface proteins, and histology at each tissue spot, yet most spatial domain discovery methods provide only cluster assignments, without indicating assignment reliability, modality contributions, or why a domain decision should be trusted. We present OmicSync, a reliability-aware spatial multi-omics framework that couples unsupervised domain clustering with evidence-constrained LLM reasoning using model-derived per-spot signals, including assignment confidence, epistemic routing uncertainty, and modality-routing weights. These signals are converted into structured evidence dictionaries and used to generate standard, stepwise, counterfactual, contrastive, and uncertainty-focused explanations. OmicSync integrates a KAN-GCN backbone with spatial encoding, cross-modal fusion, uncertainty-aware routing, cell-type supervision, and missing-modality imputation. We further introduce OmicSync-R, which closes the reasoning-clustering loop by using automatically computed reasoning-quality scores as REINFORCE rewards, allowing reasoning coherence to shape the latent structure without backpropagating through the language model. Across four 10x CytAssist FFPE spatial proteomics benchmarks, OmicSync achieves the best average rank on Human Tonsil (1.44), Glioblastoma (1.78), and Tonsil Add-on (1.22), and second-best on Human Breast Cancer (2.33). OmicSync-R further improves ARI on Human Breast Cancer from 45.73 to 46.72 and outperforms existing methods on six of nine clustering metrics. Together, OmicSync and OmicSync-R enable reliability-aware, spot-level auditable spatial domain discovery guided by evidence-constrained reasoning.

0.26

MoSPR: Histology-to-Gene Expression Prediction with Morpho-Spatial Macrostates and Low-Rank Molecular Programs

cs.AI cs.CVcs.LG ·2026-09-28 ·Dongmyung Shin, Geongyu Lee, Yesung Cho, Park Jong Bae
code/data similarity 0.56
Abstract

Predicting molecular profiles from histopathology remains challenging because whole-slide images contain spatially organized, heterogeneous tissue patterns, while gene expression comprises thousands of correlated targets. We introduce MoSPR (Morpho-Spatial Program Regression), a linear framework that couples an adjacency-informed histology representation with a low-rank molecular basis. MoSPR clusters frozen patch embeddings into morphology microstates, aggregates their spatial adjacencies across the training cohort, and groups microstates with similar adjacency patterns into shared macrostates. Each slide is then represented by global morphology and macrostate-specific deviations, which are linearly mapped to coefficients of a training-derived low-rank gene-expression basis. Across three cancer cohorts from The Cancer Genome Atlas, MoSPR achieves the highest mean gene-expression prediction scores among all evaluated methods. Without pathway-level supervision, pathway scores derived from its predicted expression profiles rank first in eight of nine comparisons across three pathway collections. Ablation studies on the breast cancer cohort show complementary gains from adjacency-derived macrostate representation and low-rank molecular prediction. Moreover, with half of the training data on this cohort, MoSPR exceeds the full-data gene-prediction score of the strongest competing baseline. Finally, its linear formulation enables exact decomposition of each predicted expression profile into global and macrostate-specific molecular contributions, providing an interpretable link between spatially coherent macrostate regions and their associated molecular programs. Our code is available at https://github.com/Radisen-Panthera/MoSPR.

0.20